Gilead has 15 products on the market.
| Brand Name | Drug Name(s) | Indication | Date Approved (USA) | Marketing Partner(s) | U.S. Patent Expiration | European Patent Expiration |
|---|---|---|---|---|---|---|
| AmBisome | liposomal amphotericin B | fungal infection, cryptococcal meningitis, Aspergillus, Candida, Cryptococcus infections | 1997-08-11 | Astellas Pharma(USA)Rapiscan(EU) | 2016 | 2008 |
| Atripla | tenofovir, emtricitabine, and efavirenz | HIV, AIDS | 2006-07-12 | Bristol-Myers Squibb | 2021 | 2018 |
| Cayston | Aztreonam | Cystic Fibrosis | 2010-02-22 | 2021 | 2021 | |
| Complera | tenofovir, emtricitabine, and rilpivirine | HIV, AIDS | 2011-08-10 | Johnson and Johnson | ||
| Emtriva | emtricitabine | HIV, AIDS | 2003-07-02 | 2021 | 2016 | |
| Flolan | epoprostenol sodium | pulmonary hypertension | 1995-09-20 | GlaxoSmithKline | expired | expired |
| Hepsera | adefovir dipivoxil | hepatitis B (HBV) | 2002-09-20 | 2014 | 2011 | |
| Letairis | ambrisentan | Pulmonary arterial hypertension | 2007-06-15 | GlaxoSmithKline | 2015 | 2015 |
| Lexiscan | regadenoson | myocardial perfusion imaging | 2008-04-10 | Astellas | 2019 | 2020 |
| Macugen | pegaptanib sodium solution | age-related macular degeneration | 2004-12-17 | OSI and Pfizer | 2017 | 2017 |
| Ranexa | ranolazine | angina | 2006-01-27 | Hoffmann–La Roche | 2019 | 2019 |
| Stribild | elvitegravir, cobicistat, emtricitabine, tenofovir | HIV, AIDS | 2012-08-27 | |||
| Tamiflu | oseltamivir phosphate | influenza | 1999-10-27 | Hoffmann–La Roche | 2016 | 2016 |
| Truvada | emtricitabine and tenofovir | HIV, AIDS | 2004-08-02 | 2021 | 2018 | |
| Viread | tenofovir | HIV, AIDS, hepatitis B | 2001-10-26 | 2017 | 2018 | |
| Vistide | cidofovir | CMV retinitis | 1996-06-26 | Pfizer | 2010 | 2012 |
Read more about this topic: Gilead Sciences
Famous quotes containing the word product:
“The product of the artist has become less important than the fact of the artist. We wish to absorb this person. We wish to devour someone who has experienced the tragic. In our society this person is much more important than anything he might create.”
—David Mamet (b. 1947)